Growing use of molecular diagnostics and monoclonal antibodies is shaping the antibody-mediated rejection market. North America holds the dominant share, while clinical trials and regulatory approvals drive global expansion in AMR treatment solutions. https://www.datamintelligence.com/research-report/antibody-mediated-rejection-market